What Colorado Beneficiaries Need to Know About Coverage, Eligibility, and the New GLP-1 Bridge Program
Author: Donald Allen, Last Revision: 06/25/2026
For years, many Medicare beneficiaries have been asking the same question: “Why doesn’t Medicare cover the GLP-1 weight loss medications like Wegovy or Zepbound?”
Beginning July 1, 2026, that answer is beginning to change.
The Centers for Medicare & Medicaid Services (CMS) is launching a new temporary initiative known as the Medicare GLP-1 Bridge Program, designed to help eligible Medicare beneficiaries gain access to certain GLP-1 medications for $50 per month.
As public interest in GLP-1 medications continues to grow, understanding how this program works and who may qualify has become increasingly important.
What Are GLP-1 Medications?
GLP-1 medications are a class of prescription drugs originally developed to help manage Type 2 diabetes. Over the past several years, they have gained widespread attention for their effectiveness in supporting weight loss and improving metabolic health.
Some of the most widely recognized GLP-1 medications include:
These medications work by helping regulate appetite, slowing digestion, and improving blood sugar regulation.
For many patients, GLP-1 medications have been associated with meaningful improvements in:
- Weight management
- Blood sugar control
- Cardiovascular health
- Blood pressure
- Overall metabolic wellness
Why This Matters for Medicare Beneficiaries
Historically, Medicare has offered very limited coverage for weight loss medications when prescribed solely for obesity treatment.
This has created a major affordability barrier, as many GLP-1 medications can cost hundreds to over a thousand dollars per month, without the necessary diagnosis and authorization.
The new GLP-1 Bridge Program is designed to improve access to Medicare beneficiaries while Medicare evaluates long-term coverage policies and healthcare outcomes.
For many beneficiaries, this could create opportunities that previously did not exist.
Who May Qualify for the GLP-1 Bridge Program?
Eligibility is based on medical necessity and specific clinical criteria.
In general, individuals may qualify if they:
- Enrolled in Medicare Part D or a Medicare Advantage plan with prescription drug coverage
- Meet certain BMI and/or obesity-related clinical requirements
- Have qualifying health conditions or associated risk factors
- Receive physician approval and complete prior authorization
Potential qualifying conditions may include:
- Obesity
- High blood pressure
- Cardiovascular disease
- Chronic kidney disease
- Pre-diabetes or diabetes-related risk factors
- Prior heart attack or stroke
Final eligibility is determined through clinical review and medical documentation.
Need Help Navigating the GLP-1 Bridge Approval Process?
The GLP-1 Bridge Program approval process might feel overwhelming, especially when prior authorization, medical documentation, and Medicare coverage requirements are involved, we are happy to help.
AIS Medicare & More is available to help individuals better understand the process. We can help ensure you and your healthcare providers have the necessary documentation and forms to ensure things move as smoothly as possible.
There is no cost for this assistance, and you do not need to be a current AIS client to receive guidance. Our goal is simple: to help Colorado beneficiaries access clear, reliable support when navigating complex healthcare coverage questions. We proudly serve communities across Colorado through multiple office locations, offering both in-person support and virtual or phone consultations. Whether you prefer to meet face-to-face or connect remotely, we are here to help.
Important Details Beneficiaries Should Understand
While the $50 monthly cost has attracted significant attention, there are important details beneficiaries should understand before assuming eligibility.
This is not standard Medicare drug coverage
The GLP-1 Bridge Program operates separately from traditional Medicare Part D coverage. While Medicare beneficiaries are required to have a Drug Plan active, the GLP-1 Bridge program will not utilize your policy to manage claims or authorizations. This means your provider will not be submitting the authorization documents to your Drug Plan Provider, but to the central processing system from Centers for Medicare & Medicaid Services (CMS) and your pharmacy.
That means:
- Different approval requirements
- Claims will get processed differently than standard prescriptions
- Coverage rules of your insurance company do not apply
GLP-1 medications included in GLP-1 Bridge Program
Not all GLP-1 medications are automatically available under the program.
Medication eligibility depends on CMS program guidelines, clinical approval, and participating coverage pathways. The GLP-1 Bridge program is starting with 3 GLP-1 medications:
- Wegovy
- Offers both a once weekly, injection and pill
- Zepound
- Offers a once weekly, injection
- Foundayo
- Offers a once daily, pill
Prior Authorization process
Even when a beneficiary appears eligible, physician approval and documentation are still going to be required, but in a different way than a typical medication authorization.
The GLP-1 bridge program authorization steps:
- Must not have a diagnosis that qualifies for GLP-1 currently, this consists of:
- Obstructive Sleep Apnea
- Noncirrochtic Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Type 2 Diabetes
- Major cardiovascular events
- If any of the above diagnoses are established for a Medicare beneficiary then the GLP-1 Bridge Program cannot be used to reduce the cost of the medication.
- Prescribing provider must submit GLP-1 medication to the pharmacy (of your choice) in the standard manner they would and indicate to send to Medicare GLP-1 Bridge.
- Must meet at least one of the GLP-1 Bridge program criteria, this consists of:
- If there was prescription and usage of a GLP-1 (any time), the provider can list your BMI at the time initially prescribed
- BMI of 35 and higher
- Nothing else is required to get one of the three, GLP-1 medications
- BMI of 30-34 and at least one of the following diagnosis:
- Chronic Kidney Disease, stage 3a and above
- Uncontrolled hypertension
- Heart Failure with preserved ejection fraction
- BMI of 27-29 and at least one of the following diagnosis:
- Pre-diabetes, per American Diabetes Association Guidelines
- Previous Myocardial Infarction
- Symptomatic Peripheral Artery Disease
- Previous Stroke
- Prescribing provider must fill out authorization form indicating eligibility.
- Prescribing provider must submit Prior Authorization form to the Pharmacy and/or Central Processor
What This Means for Colorado Medicare Beneficiaries
Across Colorado, from Littleton and Boulder to Colorado Springs, Pueblo, and rural communities, we continue to see increased interest in preventative healthcare and chronic disease management among older adults.
GLP-1 medications have quickly become one of the most discussed prescription categories in healthcare, especially among Medicare beneficiaries concerned about obesity, cardiovascular risk, diabetes, and long-term wellness.
For many Coloradans, the greatest challenge is not awareness of these medications, but understanding eligibility, prior authorization requirements, coverage limitations, and real out-of-pocket costs.
As Medicare evolves, beneficiaries increasingly need trusted resources to help interpret policy changes and understand how they may affect individual healthcare decisions.
Expert Perspective from Donald Allen
According to Donald Allen at AIS Medicare & More, programs like the Medicare GLP-1 Bridge Program reflect a broader shift in how Medicare is approaching preventative and chronic care.
“We’re seeing more Medicare beneficiaries ask about GLP-1 medications than ever before. The biggest confusion isn’t whether these medications work, it’s understanding who qualifies, what Medicare actually covers, and what costs may still exist. As Medicare rules evolve, education becomes more important than ever.”
-Donald Allen, aIS Medicare & more
As Medicare continues changing, beneficiaries need clear, reliable guidance to understand how new programs may affect healthcare decisions, prescription costs, and long-term planning.
Donald Allen and the AIS Medicare & More team are happy to help!
About AIS Medicare & More
AIS Medicare & More is an independent Colorado-based health insurance brokerage serving Medicare and health insurance clients throughout the state of Colorado.
AIS specializes in Medicare education, plan comparisons, retirement healthcare planning, and Affordable Care Act coverage, with a mission centered on helping individuals make informed healthcare decisions through education-first guidance and long-term support.
More Resources:
CMS GLP-1 Bridge Program Overview
